ECG Devices Market Size Will Achieve USD 8,611 Million by 2030 growing at 5.6% CAGR

The Global ECG devices market Size accounted for USD 5,284 million in 2021 and is projected to attain a size of around USD 8,611 million by 2030 growing with a CAGR of 5.6% for the forecast period 2022 to 2030, as reported by Acumen Research and Consulting

An electrocardiogram (ECG) is one of the easiest and quickest tests used to examine the heart. Operating rooms and ambulances come equipped with ECG units as normal. One of the prevalent trends in the market for ECG devices that is fueling the growth is the increasing integration of ECG systems in wearable devices. Similar to this, incorporating artificial intelligence (AI) into ECG is another significant ECG devices market trend that is boosting industry growth. Over the past two years, a number of this research have been presented at the American Heart Association (AHA) convention and published in cardiology journals. The next generation of ECG devices will probably include these kinds of algorithms as alternatives. The FDA approved AliveCor's next-generation interpretive AI-based personal ECG algorithms for its Kardia device in November 2020, allowing it to diagnose atrial fibrillation and a variety of other cardiac problems.

Download Sample Report Copy From Here: https://www.acumenresearchandconsulting.com/request-sample/2385

Some Of The Key Observations Regarding the ECG Devices Industry Include

• LifeSignals Group has received FDA 510(k) clearance for its ECG Remote Monitoring Patch Platform in 2020. The ECG Remote Monitoring Patch Platform is a wireless remote monitoring system that is used by healthcare professionals in ambulatory, hospital, home, and healthcare settings. The new platform records data that is transmitted wirelessly to a remote server for storage and analysis.

• In 2020, the Electronics and Telecommunications Research Institute (ETRI) and a midsize medical device company have jointly developed a monitoring system, which includes a device consists of a biometric signal measuring device (VDR-1000) and a patient monitoring device (VMA-1000). The VDR-1000 measures the patient's electrocardiogram (ECG), pulse wave, pulse, respiration, and blood pressure and sends the recorded values to VMA-1000 which allows the healthcare professionals to monitor the COvid-19 infected patients' condition in real-time.

• In 2020, GS Elektromedizinische Geraete G. Stemple GmbH and VectraCor Inc. have announced an agreement, particularly to incorporate VectraCor's cloud-based version of VectraCor's derived 22-Lead ECG and Cardiac Electrical Biomarker technology into corpuls defibrillators.

• In 2020, Withings, a French consumer electronics company has announced a $60 million Series B funding round that will be co-led by Gilde Healthcare, Idinvest Partners and Bpi France, through their Large Venture funds, as well as BNP Paribas Développement, ODDO BHF, and Adelie Capital.

• Philips has launched remote monitoring and defibrillator solution (Tempus ALS) for pre-hospital settings in the U.S. The company has received 510(k) clearance from the FDA for its pre-hospital wireless monitoring solution (Tempus LS- Manual). The software platform provides robust, real-time transfer of clinical data and events, interactive ECG measurement, and two-way communication among others.

Customization Request: https://www.acumenresearchandconsulting.com/request-sample/2385

COVID-19 Impact on the Global ECG Devices Market Revenue

The rising popularity of wearable gadgets, as well as the boom in remote patient monitoring during the COVID-19 outbreak, has raised demand for wireless ECG monitors. Furthermore, the increasing acceptance of home-based ECG due to the global increase in coronavirus patients created huge growth prospects for the market. Furthermore, as the prevalence of arrhythmia disorders among SARS-CoV-2 patients has grown, remote wireless rhythm monitoring using ECG has become more widespread, signaling a positive impact on the industry in the near future.

ECG Devices Market Dynamics

Rising incidence of lifestyle and cardiovascular diseases, and increasing geriatric population are the leading factors that are driving the ECG devices market growth. Additionally, the increasing R&D activities and technological advancements in wireless monitoring and wearable devices are supporting the ECG devices market share. However, lack of skilled professionals in this industry is restricting the ECG devices market value. Furthermore, untapped emerging markets would open up numerous growth opportunities in the coming future.

ECG Devices Market Segmentation

The ECG devices market is segmented based on product type, end-user, and geography. By product type, the market is divided into monitoring ECG systems, and diagnostic ECG systems including rest ECG Systems, Stress ECG Systems, and Holter ECG Systems. Based on end-user, market segments include hospitals, clinics, ambulatory surgical centers, and others.
Based on product type, monitoring the ECG systems segment is leading the ECG devices market with maximum revenue share (%) in 2021. The monitoring ECG systems are further segmented into remote data monitoring, event monitoring, and continuous cardiovascular monitoring systems. The declining cost of wireless technologies simultaneously increasing the incidence of cardiovascular diseases where monitoring of heart activities is important is the factor driving the segmental market value. The increasing demand for home ECG devices is boosting the segmental market value.

ECG Devices Market Regional Outlook

North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa are the regional categorizations of the ECG devices industry.

In 2021, North America held the major share (%) of the global ECG devices market. The presence of major players in the regional market including AliveCor Inc., CardioComm Solutions Inc., GE Healthcare, and iRhythm Technologies Inc. are contributing to the regional market value. The rapidly increasing geriatric population, as well as rising incidences of cardiovascular diseases, is also supporting the regional ECG devices market value. Additionally, the well-established healthcare infrastructure in the US and Canada is further contributing to the regional market value.

Apart from these, the Asia Pacific region is anticipated to experience the fastest growth with a major CAGR (%) over the forecast period from 2022 to 2030. The emerging economies, developing healthcare infrastructure, increasing disposable income coupled with the increasing spending on healthcare solutions, favorable government policies, and increasing investment by the market players in the region to take advantage of available opportunities are the factors supporting the regional market value. The developing economies of the region including China and India are contributing to the regional ECG devices market size.

ECG Devices Market Players

Some of the leading ECH devices manufacturers are Aerotel Medical Systems Ltd, AliveCor Inc., BPL Medical Technologies, Cardiocity Limited, CardioComm Solutions Inc., GE Healthcare, iRhythm Technologies Inc., MediBioSense Ltd, Medtronic PLC, and Nihon Kohden Corporation. ECG devices companies have announced strategic mergers and acquisitions, partnerships and collaborations, and new product development to expand their position in the ECG devices industry. Major players are also moving into new regions with advanced technologies for gaining a competitive advantage.

Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/2385

Browse Our More Press Releases: https://www.acumenresearchandconsulting.com/press-releases

Related Reports:-

Electrosurgery Market https://www.acumenresearchandconsulting.com/electrosurgery-market

STD Testing Market https://www.acumenresearchandconsulting.com/std-testing-market

201, Vaidehi-Saaket, Baner - Pashan Link Rd, Pashan, Pune, Maharashtra 411021

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

This release was published on openPR.